We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Lear
LEA
$8.06B
| $11.6M | 0.05% |
80,930
+43,491
| +116% | +$5.74M |
|
427
Edwards Lifesciences
EW
$53.5B
| $11.5M | 0.05% |
122,025
-728,713
| -86% | -$63.3M |
|
428
Peloton Interactive
PTON
$2.38B
| $11.5M | 0.05% |
1,492,716
+1,143,905
| +328% | +$9.72M |
|
429
DTE Energy
DTE
$28.7B
| $11.5M | 0.05% |
104,139
-211,437
| -67% | -$23.6M |
|
430
Progressive
PGR
$121B
| $11.3M | 0.05% |
85,739
-20,245
| -19% | -$2.71M |
|
431
American Electric Power
AEP
$67.4B
| $11.3M | 0.05% |
134,584
+121,299
| +913% | +$10.7M |
|
432
Intapp
INTA
$3.05B
| $11.3M | 0.05% |
269,870
+236,003
| +697% | +$10.2M |
|
433
Sarepta Therapeutics
SRPT
$1.93B
| $11.2M | 0.05% |
97,977
-196,233
| -67% | -$25.3M |
|
434
Li Auto
LI
$12.3B
| $11.1M | 0.05% |
316,751
+284,215
| +874% | +$7.99M |
|
435
Integra LifeSciences
IART
$1.34B
| $11M | 0.05% |
267,905
+168,751
| +170% | +$8.12M |
|
436
Twist Bioscience
TWST
$7.84B
| $11M | 0.05% |
537,098
-145,552
| -21% | -$2.18M |
|
437
KE Holdings
BEKE
$19.1B
| $10.9M | 0.05% |
736,104
-927,813
| -56% | -$15.1M |
|
|
RVNC
438
DELISTED
Revance Therapeutics, Inc.
RVNC
| $10.9M | 0.05% |
431,096
+266,070
| +161% | +$8.29M |
|
439
RenaissanceRe
RNR
$13.2B
| $10.9M | 0.05% |
58,328
+36,074
| +162% | +$7.18M |
|
|
CHX
440
DELISTED
ChampionX
CHX
| $10.9M | 0.05% |
350,482
-328,220
| -48% | -$9.04M |
|
441
Canadian Imperial Bank of Commerce
CM
$110B
| $10.9M | 0.05% |
254,469
-7,358
| -3% | -$311K |
|
442
Fortinet
FTNT
$120B
| $10.8M | 0.05% |
143,086
+121,680
| +568% | +$8.27M |
|
443
Amphastar Pharmaceuticals
AMPH
$847M
| $10.8M | 0.05% |
187,939
+114,995
| +158% | +$5.1M |
|
444
Jacobs Solutions
J
$16.9B
| $10.7M | 0.05% |
109,068
+11,255
| +12% | +$1.07M |
|
445
Everest Group
EG
$14B
| $10.7M | 0.05% |
+31,340
| New | +$11.3M |
|
446
Penumbra
PEN
$12.8B
| $10.7M | 0.05% |
+31,107
| New | +$9.55M |
|
|
MRO
447
DELISTED
Marathon Oil Corporation
MRO
| $10.7M | 0.05% |
464,363
-167,070
| -26% | -$3.93M |
|
448
Fabrinet
FN
$20.9B
| $10.6M | 0.05% |
81,986
-18,699
| -19% | -$2M |
|
449
Builders FirstSource
BLDR
$7.81B
| $10.6M | 0.05% |
78,050
-13,882
| -15% | -$1.54M |
|
450
Trupanion
TRUP
$1.32B
| $10.6M | 0.05% |
538,093
+510,520
| +1,852% | +$14.4M |
|
Similar funds
CS
VAI
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.